Variant report
Variant | nsv4419 |
---|---|
Chromosome Location | chr4:91582393-91612970 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:56)
- CpG islands (count:62)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr4:91583327-91583418 | GM13977 | blood: | n/a | n/a |
2 | CTCF | chr4:91590640-91590790 | AG10803 | skin: | n/a | n/a |
3 | E2F4 | chr4:91585122-91585322 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | EBF1 | chr4:91591438-91591741 | GM12878 | blood: | n/a | chr4:91591567-91591578 |
5 | EBF1 | chr4:91591375-91591736 | GM12878 | blood: | n/a | chr4:91591567-91591578 |
6 | EBF1 | chr4:91591266-91591821 | GM12878 | blood: | n/a | chr4:91591567-91591578 |
7 | EP300 | chr4:91591376-91591612 | GM12878 | blood: | n/a | n/a |
8 | FOS | chr4:91611059-91611170 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | FOS | chr4:91590035-91590161 | MCF10A-Er-Src | breast: | n/a | chr4:91590145-91590154 |
10 | FOS | chr4:91611036-91611281 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOSL2 | chr4:91596714-91596927 | HepG2 | liver: | n/a | n/a |
12 | FOXA1 | chr4:91610321-91610575 | HepG2 | liver: | n/a | chr4:91610479-91610491 |
13 | FOXA1 | chr4:91610323-91610536 | HepG2 | liver: | n/a | chr4:91610479-91610491 |
14 | FOXA1 | chr4:91610334-91610537 | HepG2 | liver: | n/a | chr4:91610479-91610491 |
15 | FOXA2 | chr4:91602296-91602678 | A549 | lung: | n/a | n/a |
16 | FOXA2 | chr4:91610353-91610547 | HepG2 | liver: | n/a | chr4:91610479-91610491 |
17 | FOXA2 | chr4:91596698-91596984 | A549 | lung: | n/a | n/a |
18 | FOXA2 | chr4:91602061-91602649 | A549 | lung: | n/a | n/a |
19 | GATA3 | chr4:91592831-91592863 | SH-SY5Y | brain: | n/a | n/a |
20 | GATA3 | chr4:91593977-91594089 | SH-SY5Y | brain: | n/a | n/a |
21 | MAFF | chr4:91606867-91607088 | HepG2 | liver: | n/a | n/a |
22 | MAFK | chr4:91606862-91607073 | HepG2 | liver: | n/a | n/a |
23 | MAFK | chr4:91606840-91607157 | HepG2 | liver: | n/a | n/a |
24 | MAFK | chr4:91606927-91607139 | IMR90 | lung: | n/a | n/a |
25 | MYC | chr4:91603819-91603888 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | NR3C1 | chr4:91596709-91596869 | A549 | lung: | n/a | n/a |
27 | NR3C1 | chr4:91596751-91596849 | A549 | lung: | n/a | n/a |
28 | PBX3 | chr4:91596743-91596891 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr4:91589346-91589472 | GM12878 | blood: | n/a | n/a |
30 | POLR2A | chr4:91584361-91584381 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr4:91596708-91596871 | HepG2 | liver: | n/a | n/a |
32 | POLR2A | chr4:91612391-91612679 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr4:91610533-91610641 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | POLR2A | chr4:91595109-91595211 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | POLR2A | chr4:91589493-91589497 | GM12878 | blood: | n/a | n/a |
36 | POLR2A | chr4:91604469-91604639 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr4:91582429-91582430 | GM12878 | blood: | n/a | n/a |
38 | POLR2A | chr4:91611769-91611777 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr4:91596755-91596853 | A549 | lung: | n/a | n/a |
40 | POLR2A | chr4:91582719-91582924 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | POLR2A | chr4:91593023-91593143 | GM12878 | blood: | n/a | n/a |
42 | POLR2A | chr4:91587280-91587449 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | POLR2A | chr4:91596721-91596853 | A549 | lung: | n/a | n/a |
44 | POLR2A | chr4:91608667-91608742 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | RUNX3 | chr4:91591355-91591703 | GM12878 | blood: | n/a | n/a |
46 | SPI1 | chr4:91591352-91591638 | GM12878 | blood: | n/a | n/a |
47 | SPI1 | chr4:91591342-91591670 | GM12891 | blood: | n/a | n/a |
48 | SPI1 | chr4:91591319-91591654 | GM12891 | blood: | n/a | n/a |
49 | SPI1 | chr4:91586916-91587309 | HL-60 | blood: | n/a | n/a |
50 | SRF | chr4:91596783-91596892 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:91606776-91606826 | HCM | heart: | n/a |
2 | chr4:91606776-91606826 | HCM | heart: | n/a |
3 | chr4:91606776-91606826 | K562 | blood: | n/a |
4 | chr4:91606776-91606826 | NH-A | brain: | n/a |
5 | chr4:91606776-91606826 | GM19239 | blood: | n/a |
6 | chr4:91606776-91606826 | MCF10A-Er-Src | breast: | n/a |
7 | chr4:91606776-91606826 | H1-hESC | embryonic stem cell: | embryo |
8 | chr4:91606776-91606826 | HCPEpiC | choroid plexus: | n/a |
9 | chr4:91606776-91606826 | NHDF-neo | bronchial: | n/a |
10 | chr4:91606776-91606826 | Jurkat | blood: | n/a |
11 | chr4:91606776-91606826 | AG09309 | skin: | n/a |
12 | chr4:91606776-91606826 | Caco-2 | colon: | n/a |
13 | chr4:91606776-91606826 | NB4 | blood: | n/a |
14 | chr4:91606776-91606826 | AG04450 | lung: | fetal |
15 | chr4:91606776-91606826 | SKMC | muscle: | n/a |
16 | chr4:91606776-91606826 | ECC-1 | luminal epithelium: | n/a |
17 | chr4:91606776-91606826 | Hepatocyte | liver: | n/a |
18 | chr4:91606776-91606826 | A549 | lung: | n/a |
19 | chr4:91606776-91606826 | HMEC | breast: | n/a |
20 | chr4:91606776-91606826 | AoSMC | blood vessel: | n/a |
21 | chr4:91606776-91606826 | AG10803 | skin: | n/a |
22 | chr4:91606776-91606826 | T-47D | breast: | n/a |
23 | chr4:91606776-91606826 | HL-60 | blood: | n/a |
24 | chr4:91606776-91606826 | HCF | heart: | n/a |
25 | chr4:91606776-91606826 | SK-N-MC | brain: | n/a |
26 | chr4:91606776-91606826 | IMR90 | lung: | fetal |
27 | chr4:91606776-91606826 | GM12891 | blood: | n/a |
28 | chr4:91606776-91606826 | BJ | skin: | n/a |
29 | chr4:91606776-91606826 | Hela-S3 | cervix: | n/a |
30 | chr4:91606776-91606826 | HEK293 | kidney: | embryo |
31 | chr4:91606776-91606826 | HPAEpiC | pulmonary alveolar: | n/a |
32 | chr4:91606776-91606826 | HIPEpiC | eye: | n/a |
33 | chr4:91606776-91606826 | GM12892 | blood: | n/a |
34 | chr4:91606776-91606826 | SK-N-SH_RA | brain: | n/a |
35 | chr4:91606776-91606826 | PFSK-1 | brain: | n/a |
36 | chr4:91606776-91606826 | HRE | kidney: | n/a |
37 | chr4:91606776-91606826 | AG04449 | skin: | fetal |
38 | chr4:91606776-91606826 | HUVEC | blood vessel: | n/a |
39 | chr4:91606776-91606826 | LNCaP | prostate: | n/a |
40 | chr4:91606776-91606826 | HRCEpiC | kidney: | n/a |
41 | chr4:91606776-91606826 | HRPEpiC | eye: | n/a |
42 | chr4:91606776-91606826 | HEEpiC | esophagus: | n/a |
43 | chr4:91606776-91606826 | ovcar-3 | ovarian: | n/a |
44 | chr4:91606776-91606826 | SK-N-SH | brain: | n/a |
45 | chr4:91606776-91606826 | PANC-1 | pancreas: | n/a |
46 | chr4:91606776-91606826 | U87 | brain: | n/a |
47 | chr4:91606776-91606826 | HCT-116 | colon: | n/a |
48 | chr4:91606776-91606826 | HepG2 | liver: | n/a |
49 | chr4:91606776-91606826 | HNPCEpiC | eye: | n/a |
50 | chr4:91606776-91606826 | RPTEC | kidney: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251401 | TF binding region |
ENSG00000251401 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557786952 | chr4:91596606-91596607 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577836774 | chr4:91596628-91596629 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115443098 | chr4:91596638-91596639 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188093289 | chr4:91596639-91596640 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181299839 | chr4:91596679-91596680 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542704728 | chr4:91596691-91596692 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11731861 | chr4:91596734-91596735 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs62314419 | chr4:91596735-91596736 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545556696 | chr4:91596746-91596747 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10559291 | chr4:91596768-91596769 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs397813467 | chr4:91596770-91596771 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs397786416 | chr4:91596771-91596772 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371270727 | chr4:91596794-91596795 | Enhancers ZNF genes & repeats Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376349820 | chr4:91596821-91596822 | Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs202110645 | chr4:91596823-91596824 | Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368430169 | chr4:91596826-91596827 | Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200385135 | chr4:91596831-91596832 | Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374639261 | chr4:91596855-91596856 | Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374795520 | chr4:91596891-91596892 | Enhancers ZNF genes & repeats Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112735243 | chr4:91602654-91602655 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs144010585 | chr4:91603121-91603122 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs553792271 | chr4:91603160-91603161 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs567332903 | chr4:91603175-91603176 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs78658733 | chr4:91603194-91603195 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs367830965 | chr4:91603197-91603198 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs567882826 | chr4:91603833-91603834 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs536263022 | chr4:91603837-91603838 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs79355899 | chr4:91603858-91603859 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs570096430 | chr4:91603877-91603878 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs367815173 | chr4:91607027-91607028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6851780 | chr4:91607034-91607035 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs374671933 | chr4:91607100-91607101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548206559 | chr4:91607110-91607111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs528680083 | chr4:91607176-91607177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546239605 | chr4:91607185-91607186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547164330 | chr4:91607295-91607296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6856591 | chr4:91607363-91607364 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs550428480 | chr4:91607427-91607428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531714922 | chr4:91607430-91607431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149879713 | chr4:91607463-91607464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191600757 | chr4:91607479-91607480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553183329 | chr4:91607480-91607481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573222400 | chr4:91607490-91607491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs6857209 | chr4:91607596-91607597 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs562208747 | chr4:91607633-91607634 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs73833776 | chr4:91607634-91607635 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146414923 | chr4:91607671-91607672 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs17183079 | chr4:91607686-91607687 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139980758 | chr4:91607694-91607695 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185313750 | chr4:91607759-91607760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:91596600-91596800 | Active TSS | K562 | blood |
2 | chr4:91596600-91597000 | Enhancers | Primary T cells from cord blood | blood |
3 | chr4:91596600-91597000 | ZNF genes & repeats | Primary hematopoietic stem cells | blood |
4 | chr4:91596800-91597000 | Flanking Active TSS | K562 | blood |
5 | chr4:91607000-91607600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr4:91607000-91608200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr4:91607600-91610800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr4:91607800-91608000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr4:91608000-91610400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
10 | chr4:91608200-91610800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr4:91608800-91609000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr4:91610200-91612000 | Enhancers | HMEC | breast |
13 | chr4:91610400-91612200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr4:91610600-91610800 | Enhancers | NHEK | skin |
15 | chr4:91610600-91612000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
16 | chr4:91610600-91612200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr4:91610800-91611200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr4:91610800-91611200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr4:91610800-91611200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr4:91610800-91611400 | Flanking Active TSS | NHEK | skin |
21 | chr4:91610800-91612000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
22 | chr4:91611000-91611400 | Enhancers | H9 Cell Line | embryonic stem cell |
23 | chr4:91611400-91612200 | Enhancers | NHEK | skin |
24 | chr4:91612200-91615600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |